Key Financial Data Of Group

KYORIN Pharmaceutical Co., Ltd. - Filing #7721845

Concept As at
2018-06-30
2018-04-01 to
2018-06-30
2017-04-01 to
2018-03-31
As at
2018-03-31
As at
2017-06-30
2017-04-01 to
2017-06-30
Key financial data of group
Business results of group
Net sales
25,131,000,000 JPY
110,640,000,000 JPY
26,458,000,000 JPY
Ordinary profit (loss)
1,596,000,000 JPY
9,345,000,000 JPY
2,805,000,000 JPY
Profit (loss) attributable to owners of parent
1,077,000,000 JPY
6,574,000,000 JPY
2,393,000,000 JPY
Comprehensive income
307,000,000 JPY
9,132,000,000 JPY
3,351,000,000 JPY
Net assets
160,790,000,000 JPY
163,297,000,000 JPY
158,497,000,000 JPY
Total assets
192,184,000,000 JPY
196,736,000,000 JPY
190,626,000,000 JPY
Basic earnings (loss) per share
14.60
89.28
32.54
Diluted earnings per share
Equity-to-asset ratio
0.837 xbrli:pure
0.830 xbrli:pure
0.831 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.